Dolocox

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dolocox

Quick Facts: Dolocox

Property Description
Active ingredient Celecoxib (INN)
Form Capsule (Oral administration)
Pharmacological class Selective COX-2 Inhibitor
General purpose Anti-inflammatory and pain relief
Origin Synthetic compound

What Type of Medicine is Dolocox? (Definition and Classification)

Dolocox is a prescription-only medicine whose active component, Celecoxib, classifies it as a Nonsteroidal Anti-inflammatory Drug (NSAID). It is a synthetic compound, supplied for oral administration in the form of capsules. The International Nonproprietary Name (INN), Celecoxib, is a derivative containing a sulfonamide chemical group.

Its critical feature, which differentiates it from the earliest NSAIDs, is its designation as a selective cyclooxygenase-2 (COX-2) inhibitor. This characteristic makes Celecoxib a modern, targeted option in its class, clinically recognized for focusing its effect on the inflammatory pathways.


Composition and General Therapeutic Purpose (The Role of Celecoxib)

The therapeutic effect of Dolocox is provided entirely by the single active ingredient, Celecoxib, which works to diminish the body's inflammatory signals. The general therapeutic purpose is to provide combined anti-inflammatory and analgesic (pain-relieving) effects, often in scenarios requiring the long-term management of inflammatory symptoms.

The mechanism relies on the selective blocking of the COX-2 enzyme, which is the primary driver of inflammation. By inhibiting this enzyme, the drug substantially reduces the local synthesis of prostaglandins. This targeted suppression of inflammatory mediators is the core benefit delivered by Dolocox, providing a focused response to inflammatory pain.

What side effects are possible with Dolocox?

Possible Side Effects and Safety Information

The safety profile of Dolocox (Celecoxib) is formally documented by government regulators (such as the FDA and EMA) and is primarily categorized by the frequency and severity of potential adverse reactions. The medicine carries regulatory warnings regarding the potential for Serious Cardiovascular Thrombotic Events (e.g., Myocardial Infarction and Stroke) and Serious Gastrointestinal Adverse Events (e.g., bleeding, ulceration, or perforation), which can occur without warning and may be fatal.


Adverse Reactions by Frequency and System-Organ Class

Adverse reactions are classified using standard regulatory frequency bands, including Very Common, Common, Uncommon, and Rare. Side effects are mapped to the affected physiological systems:

Classification Examples of Documented Reactions
Very Common Vascular Disorders (e.g., Hypertension/High Blood Pressure).
Common Gastrointestinal Disorders (e.g., abdominal pain, dyspepsia, nausea), Nervous System Disorders (e.g., headache, dizziness), Renal Disorders (e.g., fluid retention/peripheral oedema), and upper respiratory tract infections.

Population and Duration-Related Safety

The risk of serious cardiovascular events may increase with the duration of use. Furthermore, specific safety considerations apply to certain populations. Older adults are at a greater risk for serious gastrointestinal events. The medicine is generally avoided in patients with severe hepatic or renal impairment and starting at 30 weeks of gestation in pregnant women due to potential fetal risk.

Safety-Related Restrictions

Official labeling mandates that the medicine is contraindicated (should not be used) in patients with a known sulfonamide allergy, a history of allergic reactions to aspirin or other NSAIDs, active gastrointestinal bleeding or ulceration, and established Ischaemic Heart Disease or moderate-to-severe Heart Failure.

Overdose and Emergency Response

Overdose and When to Seek Help

Ingestion of Dolocox (etoricoxib) beyond the prescribed amount requires immediate emergency medical attention. The official regulatory documentation indicates that there have been no unique adverse effects reported following acute overdose of etoricoxib. However, in clinical studies involving single doses up to 500 mg or multiple daily doses up to 150 mg for 21 days, the most commonly observed clinical manifestations were consistent with the drug's known safety profile: gastrointestinal disturbances and renal toxicities.

Overdose-related risks are therefore primarily structured around the potential for these organ system toxicities, which can include severe symptoms such as acute kidney injury or severe abdominal pain, and may involve cardiovascular complications.

Emergency Actions Required

If an overdose is suspected, immediately contact emergency services or go to the nearest hospital emergency department. Bring the medicine packaging with you. The emergency management strategy outlined in official regulatory documents involves general supportive measures and the application of procedures to eliminate non-absorbed medicinal product from the gastrointestinal tract, if deemed appropriate by medical professionals. Dialysis is generally considered an ineffective means of removal because of the drug's high plasma protein binding.

Seeking prompt professional assistance is critical because the serious potential complications, though rare, can involve multi-organ system toxicity that requires urgent clinical intervention.

Therapeutic Uses of Dolocox

Quick Facts

  • Relief of Symptoms in Osteoarthritis (OA): Intended to assist in the management of pain and inflammation associated with OA.
  • Management of Rheumatoid Arthritis (RA): Used for the symptomatic relief of pain and inflammation related to RA.
  • Support for Ankylosing Spondylitis (AS): Provides relief of symptoms related to pain and inflammation in AS.
  • Acute Gouty Arthritis: Indicated for managing the pain and signs of inflammation during episodes of acute gouty arthritis.

Dolocox (Celecoxib) is a medication utilized for the symptomatic relief of chronic inflammatory conditions. Its principal approved uses focus on supporting individuals with joint and musculoskeletal issues.

The medication is indicated for the management of the signs and symptoms associated with osteoarthritis (OA). It also offers symptomatic relief for patients navigating the challenges of rheumatoid arthritis (RA) and ankylosing spondylitis (AS).

Furthermore, Dolocox is used in the short-term context for managing the pain and inflammation that may accompany an acute episode of gouty arthritis. This treatment option is designed to assist in addressing the inflammatory component of these conditions, helping to support patient comfort and overall function.

This medication is part of a broader therapeutic approach and its use should align with the established medical regimen developed by a healthcare professional.

Eligibility and Restrictions for Use

The official regulatory profile for Dolocox (Celecoxib) strictly defines which populations are eligible for use and which are absolutely excluded.

Populations Excluded from Use (Contraindicated)

The medicine must not be used by patients with:

  • Known hypersensitivity to Celecoxib, sulfonamides, or any history of allergic-type reactions (such as asthma or hives) after taking Aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs).
  • Active gastrointestinal (GI) bleeding or peptic ulceration, Inflammatory Bowel Disease (IBD), or severe heart failure (NYHA Class II-IV).
  • Severe hepatic dysfunction (Child-Pugh Class C) or severe renal impairment (creatinine clearance <30 ml/min).
  • Treatment of pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Age and Conditional Eligibility

  • Adults are generally eligible for approved uses. Pediatric use is approved only for Juvenile Rheumatoid Arthritis (JRA) in patients 2 years of age and older; use in children younger than 2 years is not established.
  • Pregnancy is a contraindication starting at 30 weeks gestation (third trimester). Use is not recommended during breastfeeding.
  • Patients with moderate hepatic impairment require a 50% dose reduction as specified in regulatory labeling. Caution is required for the elderly and those with cardiovascular risk factors.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define clinically significant interactions for Celecoxib (Dolocox) based on metabolic interference and pharmacodynamic effects.

Documented Pharmacokinetic Interactions

Celecoxib is predominantly cleared through the Cytochrome P450 2C9 (CYP2C9) enzyme. Co-administration with strong CYP2C9 inhibitors, such as Fluconazole, can result in a two-fold increase in Celecoxib plasma concentrations. Conversely, Celecoxib may inhibit the CYP2D6 enzyme, potentially increasing the exposure of co-administered drugs metabolized by this pathway, including certain antidepressants and antipsychotics.

Pharmacodynamic and Restriction-Based Interactions

Category Description (Regulatory-Aligned)
Hemorrhagic Risk Co-administration with Warfarin or other anticoagulants increases the risk of serious bleeding events, necessitating close monitoring of anticoagulant parameters (e.g., INR).
Antihypertensive Efficacy Celecoxib may diminish the blood pressure-lowering effect of ACE Inhibitors, ARBs, and Diuretics by inhibiting renal prostaglandin synthesis.
Contraindicated Use Use in the setting of peri-operative pain for Coronary Artery Bypass Graft (CABG) surgery is officially contraindicated. Concomitant use with non-aspirin NSAIDs is not recommended.

Exposure Modification

Co-administration with Lithium and Digoxin has been documented to increase the plasma levels of these substances, requiring therapeutic monitoring. Regarding administration timing, doses up to 200 mg twice daily can be taken without regard to the timing of meals; however, a high-fat meal may slightly increase total absorption (AUC).

Mechanism of Action

Pharmacodynamic Mechanism of Dolocox

The function of Dolocox is defined by the mechanism of its active ingredient, Celecoxib, which acts as a highly specific inhibitor of the Cyclooxygenase-2 ( COX-2) isoenzyme. This molecular interaction primarily occurs in biological systems where COX-2 expression is induced, while the drug largely preserves the constitutive function of COX-1.

By blocking the COX-2 enzyme, Celecoxib suppresses the molecular conversion of Arachidonic Acid into key lipid messengers, most notably Prostaglandin E2 ( PGE2). This modification of the Prostaglandin synthesis pathway results in three distinct physiological modulations: an analgesic effect via reduced pain signaling, an anti-inflammatory effect via mitigated tissue response, and an antipyretic effect via a lowered thermoregulatory set point.

However, the selective mechanism introduces a functional constraint on vascular hemostasis by reducing PGI2 synthesis (anti-thrombotic, COX-2-derived) while preserving TXA2 production (pro-thrombotic, COX-1-derived). This perturbation affects systemic processes governing vascular balance.

Dosage and Administration Information

How to Use Dolocox: Official Administration Guidelines

Dolocox (Celecoxib) is designed solely for oral administration and is supplied in a capsule formulation. The appropriate dosing regimen is determined by the specific condition being addressed, always aiming for the lowest effective dosage for the shortest duration necessary.


Standard Dosing Regimens

Condition Typical Daily Dose Range Frequency
Osteoarthritis (OA) 100 mg to 200 mg Once Daily (QD) or Twice Daily (BID)
Rheumatoid Arthritis (RA) 200 mg to 400 mg Twice Daily (BID)
Ankylosing Spondylitis (AS) 200 mg to 400 mg Once Daily or Divided
Acute Pain 400 mg initial; 200 mg subsequent As Needed (Typically BID)

Administration and Dosage Adjustments

Dolocox may generally be taken with or without food when administered at doses up to 200 mg twice daily. However, higher dosages should be administered with food to optimize absorption. The maximum daily dose for chronic indications is 400 mg.

For patients who encounter difficulty swallowing the capsule, the entire contents can be emptied and sprinkled onto a level teaspoon of certain soft foods, such as applesauce or yogurt, and must be swallowed immediately with water. Dosage modification is also a documented requirement for certain populations; for instance, the recommended daily dose is reduced by 50% for patients with moderate hepatic impairment (Child-Pugh Class B). Treatment response, particularly for chronic conditions, is subject to periodic re-evaluation as part of the official use protocol.

Recent Clinical Evidence

Research evidence / Overview of studies for Dolocox (Celecoxib)

This overview summarizes the types of official research that have evaluated Dolocox (Celecoxib) for its approved uses. It focuses on the patterns observed in the studies from randomized controlled trials (RCTs) and systematic reviews, and describes what regulators rely on as the research record. This section is a strictly descriptive, non-advisory summary of the available evidence landscape.


Evidence for Chronic Symptomatic Relief: Osteoarthritis (OA) and Rheumatoid Arthritis (RA)

The primary research studies for Dolocox evaluating outcomes in conditions associated with functional limitations like Osteoarthritis (OA) and Rheumatoid Arthritis (RA) come from numerous short-term (6-to-24-week) Randomized Controlled Trials (RCTs). These studies monitored symptomatic changes in thousands of adult patients.

Research evaluated outcomes related to physical discomfort by measuring changes in pain intensity and evaluated outcomes reflecting daily functioning or activity level using standardized tools. Research describes that measurements of symptomatic change in these trials were differentiated from the patterns reported with placebo. When examined against other non-selective NSAIDs, study findings describe patterns that were generally similar.


Evidence for Ankylosing Spondylitis (AS) and Acute Gouty Arthritis

Research explored the use of Dolocox in specific, distinct conditions characterized by fluctuating or episodic manifestations. For Ankylosing Spondylitis (AS), evidence was evaluated in intermediate-term RCTs, typically lasting 6 to 12 weeks. These studies explored outcomes related to inflammatory or irritative states, such as measurements of spinal pain intensity and morning stiffness.

For Acute Gouty Arthritis, research was studied for temporary physiological imbalance using very short-term, active-controlled RCTs. The research examined outcomes describing episodic or acute changes, focusing on the rapid measurement of changes in measurements of moderate to extreme pain intensity. High-dose regimens were evaluated against an established acute gout treatment (indomethacin), and the documented pain scores reported were similar.


What Remains Unclear: Areas of Uncertainty and Research Gaps

Official reviews note certain limitations and areas for continued research. Multi-year trials have prioritized safety outcomes, meaning the patterns of symptomatic change and the long-term measurements of reported physical function are not as thoroughly characterized by dedicated efficacy endpoints. Scientific consensus indicates that further long-term research focusing on the sustained symptomatic measurements is an identified area of uncertainty.

Frequently Asked Questions (FAQ)

Common questions about Dolocox (FAQ)

Q: Does Dolocox affect blood pressure?

A: Official information indicates that hypertension (high blood pressure) is documented as a Very Common adverse reaction in clinical trials. Regulatory warnings also note that Dolocox may diminish the blood pressure-lowering effect of certain antihypertensive drugs.

Q: How quickly does Dolocox usually start to work?

A: Regulatory documents describe that the concentration of the active ingredient, Celecoxib, typically reaches its peak level in the bloodstream about 3 hours after a dose is taken under fasting conditions. This peak level is the highest concentration of the drug in the blood, which is generally related to the time of its maximum activity.

Q: Is it okay to take Dolocox on an empty stomach?

A: Official instructions specify that doses up to 200 mg twice daily can generally be taken with or without food. However, taking the capsule with a high-fat meal can slightly delay the time it takes to reach peak levels of the medicine in the bloodstream.

Q: Can Dolocox cause problems with the liver?

A: Regulatory warnings mention the potential for Hepatotoxicity, which is damage to the liver. Official documents note that individuals should be aware of signs of liver disease, and severe liver impairment is listed as a contraindication.

Q: Why do official documents mention clinical studies about Dolocox?

A: Clinical studies are included in regulatory documents to provide the research evidence that government agencies have reviewed. This evidence is used to establish the drug's approved uses, its safety profile, and the proper conditions under which it should be used.

Q: Do studies suggest any specific groups of people respond better to Dolocox?

A: The drug is mainly broken down by the CYP2C9 enzyme in the body. Official information indicates that patients who are known or suspected to be poor metabolizers—meaning their bodies break down the drug slowly—may have higher levels of the medicine in their blood and should use the drug with caution.

Q: Is the absorption of Dolocox affected by food?

A: Yes, regulatory documents indicate that taking Dolocox with a high-fat meal delays how quickly it is absorbed. Specifically, the time to reach peak concentration is typically delayed by about 1 to 2 hours, and the total amount absorbed is slightly increased.

Q: Is Dolocox the same kind of medicine as Advil or Tylenol?

A: Dolocox is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), a drug class that includes ibuprofen (found in Advil), but it is a selective COX-2 inhibitor. In contrast, acetaminophen (found in Tylenol) is not an NSAID and works through a different mechanism to relieve pain and fever.

Q: How long does the effect of one dose of Dolocox last?

A: Regulatory documents indicate that the effective half-life of the active ingredient, Celecoxib, is approximately 11 hours in healthy individuals. The half-life is the time it takes for half of the drug to be eliminated from the body, which is a factor used in determining dosing frequency.

Q: Is Dolocox safe to take if I have stomach issues?

A: Regulatory warnings indicate that all NSAIDs, including Dolocox, carry an increased risk of serious gastrointestinal adverse events like bleeding, ulceration, or perforation. The medicine is contraindicated (should not be used) if a patient has active GI bleeding or peptic ulceration.

Q: What are the most common side effects reported for Dolocox?

A: In clinical trials, the most common adverse reactions reported in more than 2% of patients include: abdominal pain, diarrhea, indigestion (dyspepsia), gas (flatulence), swelling (peripheral edema), dizziness, and upper respiratory tract infection. Official documents also list high blood pressure as a Very Common side effect.

Q: Can I take Dolocox if I am already taking blood thinners?

A: Co-administration with blood thinners like warfarin or other anticoagulants increases the risk of serious bleeding events, requiring close monitoring. Regulatory documents also note that taking the medicine alongside antiplatelet agents (like low-dose aspirin) increases the rate of gastrointestinal complications.

Q: What foods or supplements should I be careful about when using Dolocox?

A: Regulatory documents warn that taking Dolocox with an aluminum- and magnesium-containing antacid may reduce the concentration of the drug in the body. While specific warnings for most foods and supplements are not named, strong interactions are known to occur with certain prescription medicines.

Q: What happens if I miss a dose of Dolocox?

A: Official patient information often describes a protocol where a missed dose is taken as soon as remembered. If it is almost time for the next scheduled dose, the missed dose should generally be skipped, and the regular schedule should be continued. It is generally advised that doses are not doubled.

Q: Is Dolocox safe for individuals with asthma?

A: The medicine is generally contraindicated for individuals with a history of asthma, hives, or other allergic-type reactions linked to aspirin or other NSAIDs. Regulatory information also advises that patients with pre-existing asthma should be monitored due to the potential risk of an asthma flare-up.

Q: Does Dolocox contain gluten or lactose?

A: Official information for the capsule formulation lists lactose monohydrate as an inactive ingredient. Regulatory documents do not specifically mention gluten content.

Q: Does Dolocox cause weight gain?

A: Regulatory-aligned patient information lists fluid retention (peripheral oedema) as a Common side effect. Weight gain may be listed as a potential symptom that could occur following an acute overdose of NSAIDs, including Dolocox.

Q: Can Dolocox affect mood or cause anxiety?

A: Official European product documentation lists anxiety, depression, and hallucinations as uncommon or rare adverse reactions associated with the active ingredient. These effects are classified based on post-marketing surveillance and controlled clinical trials.

Q: What is the shelf life of Dolocox tablets?

A: Regulatory information specifies that the medicine should not be used past the expiration date printed on the packaging. The drug must be stored under specific conditions to maintain its effectiveness, such as at controlled room temperature.

Q: Are there different forms of Dolocox (e.g., tablet, liquid)?

A: Official regulatory documents indicate that the medicine is supplied as an oral capsule and also an oral solution (liquid). The oral solution is approved for certain specific uses, such as acute migraine.

Q: Is it normal to feel a bit dizzy after starting Dolocox?

A: Yes, official documentation classifies dizziness as a Common adverse reaction. A common side effect is one that has been reported in clinical trials more frequently than in patients receiving an inactive substance (placebo).

Q: What kind of studies support the claims for Dolocox?

A: The official uses for Dolocox are supported by evidence from numerous short-term and intermediate-term Randomized Controlled Trials (RCTs) that evaluated symptomatic changes, pain, and physical function across thousands of adult and pediatric patients.

Q: What are the signs of a serious allergic reaction to Dolocox?

A: Regulatory documents warn that symptoms of an anaphylactic reaction may include difficulty breathing, swelling of the face or throat, hives (urticaria), and fever. Official information notes that emergency medical help is needed immediately if signs of a severe allergic reaction occur.

Q: Why are warnings included about driving while using Dolocox?

A: Official product documentation describes that individuals who experience certain side effects, such as dizziness or somnolence (drowsiness), are advised to exercise caution when performing tasks like driving or operating machinery.

Q: Are there official registry reports for side effects of Dolocox?

A: Official regulatory bodies, such as the FDA, maintain post-marketing surveillance systems to collect reports of adverse events after a medicine is approved. Serious side effects like bleeding events and acute kidney failure have been reported through these systems, especially in older patients.

Q: Why do some people say Dolocox is 'stronger' than over-the-counter options?

A: Dolocox is a prescription-only medication and a selective COX-2 inhibitor, which differentiates its function from common over-the-counter options. Regulatory research evaluated its short-term effectiveness for pain relief, and the documented findings were described as generally similar to other non-selective NSAIDs.

Q: What remains unclear regarding the long-term measurements of reported physical function, according to official reviews?

A: Official reviews note that long-duration trials have primarily focused on safety. Consequently, the patterns of symptomatic change and the long-term measurements of reported physical function have not been as fully characterized by dedicated effectiveness endpoints in those specific, extended safety trials.

Q: Is Dolocox an opioid or habit-forming drug?

A: No, Dolocox is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and a non-opioid analgesic. It works by targeting inflammatory pathways and is not described in regulatory documents as a habit-forming or controlled substance in the way opioids are.

Q: Why is Dolocox sometimes used for conditions other than pain?

A: The active ingredient, Celecoxib, is approved for treating conditions such as Osteoarthritis and Rheumatoid Arthritis due to its documented anti-inflammatory effect. It works to diminish the body's inflammatory signals, in addition to providing pain relief.

Q: How do I know if the side effects I am experiencing are considered common?

A: Official drug labels classify adverse reactions using frequency bands, such as 'Common' or 'Uncommon,' based on their occurrence in clinical trials. A common side effect is one that was reported in at least 1 in 100 people but less than 1 in 10 people during the studies.

Q: Why is there a restriction on using Dolocox for pain after CABG surgery?

A: Regulatory documents explicitly contraindicate the use of the medicine for the treatment of peri-operative pain following Coronary Artery Bypass Graft (CABG) surgery. This restriction is in place due to the documented potential for an increased risk of serious cardiovascular events.

How should Dolocox be stored and disposed of?

Official Storage and Disposal Instructions

Regulatory agencies require that Dolocox be stored under specific conditions to maintain its efficacy and safety. The product must be kept at the designated temperature, typically controlled room temperature, and stored away from excess moisture and light. It is mandatory to keep the medicine in its original, securely closed container to prevent environmental damage and potential exposure to children.

Handling and Stability:

Condition Regulatory Requirement
Temperature Store at controlled room temperature, or as specified on the label.
Child Safety Keep out of the reach of children and pets.
Outdated Product Do not use past the expiration date; outdated or damaged product must be quarantined.

Disposal:

Expired or unused Dolocox must be disposed of in a manner that protects public health and the environment. Do not flush the medication down a toilet or pour it down a drain unless explicitly instructed by official disposal guidelines. Utilize local drug take-back programs, if available, or follow federal and state instructions for safe household disposal, such as mixing with undesirable substances and discarding in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dolocox found in:

A-Z Index: